ARTICLE
14 January 2025

Key Proposals In The CY2026 Medicare Advantage And Part D Proposed Rule (Video)

SM
Sheppard, Mullin, Richter & Hampton LLP

Contributor

Businesses turn to Sheppard to deliver sophisticated counsel to help clients move ahead. With more than 1,200 lawyers located in 16 offices worldwide, our client-centered approach is grounded in nearly a century of building enduring relationships on trust and collaboration. Our broad and diversified practices serve global clients—from startups to Fortune 500 companies—at every stage of the business cycle, including high-stakes litigation, complex transactions, sophisticated financings and regulatory issues. With leading edge technologies and innovation behind our team, we pride ourselves on being a strategic partner to our clients.
This webinar will discuss key changes to the Medicare Advantage and Part D programs that are contained in CMS' proposed rule published on December 10, 2024.
United States Food, Drugs, Healthcare, Life Sciences
Christine M. Clements’s articles from Sheppard, Mullin, Richter & Hampton LLP are most popular:
  • within Food, Drugs, Healthcare and Life Sciences topic(s)
  • in Europe
Sheppard, Mullin, Richter & Hampton LLP are most popular:
  • within Cannabis & Hemp topic(s)

This webinar will discuss key changes to the Medicare Advantage and Part D programs that are contained in CMS' proposed rule published on December 10, 2024, including proposed changes related to Star Ratings, marketing and communications, agent/broker compensation, health equity, drug coverage, D-SNPs, utilization management, artificial intelligence, network adequacy, and other programmatic areas.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

[View Source]

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More